Thu, Jan 29, 2015, 2:22 PM EST - U.S. Markets close in 1 hr 38 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

desert_dweller93 1450 posts  |  Last Activity: Mar 10, 2014 10:19 PM Member since: Aug 30, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    TKMR raising $60 million

    by hwsimpsonshero Mar 10, 2014 4:34 PM
    desert_dweller93 desert_dweller93 Mar 10, 2014 10:19 PM Flag

    I bet it will be priced at where it closed ($29.74)just like with ARWR a few weeks back. As everyone knows, normally these things are priced at a discount but with the white hot RNA market we are in, I wouldn't be surprised if it went off at a premium, although that is a long shot. I would be surprised if it went off at anything less than today's close since ARWR just did a secondary a few weeks ago and they priced it at the closing price the day before. Just a few more hours to see where she prices but there is no way I would be selling in the pre market tomorrow but if you wanted to buy, it might be a good time since some sold in AH today at less than the closing priced due to the offering announcement. I predict a nice pop tomorrow just like ARWR did when they announced they didn't have to sell at a discount. GLTA.

    Sentiment: Strong Buy

  • Reply to

    Getting very impatient and annoyed

    by bricksnotbutterflies Jan 8, 2014 1:49 PM
    desert_dweller93 desert_dweller93 Jan 9, 2014 8:07 PM Flag

    b14, the fact they haven't issued a pr is not surprising to me only because as I posted over on the Google board, I spoke with Mike Gray last month and he told me they had no intention of issuing a press release upon the filing with the FDA. I told him how wrong I thought that was and he said he would pass it along but the earliest we would probably find out is possibly next week. He said they may be making some presentations surrounding the JP Morgan conference (but not at the conference) beginning on the 13th and they would probably be updating the slide deck which would contain updated status on 427, that is if they actually file by then. I have no idea if they filed or not and I am very ticked off they decided to keep this very material news to themselves. Please contact management and express your dissatisfaction.

  • Reply to

    SGEN releases latest SGN-CD19A trial results

    by redhot47fla Dec 7, 2013 10:09 AM
    desert_dweller93 desert_dweller93 Dec 8, 2013 10:21 AM Flag

    maui and atpl, thanks for the information. Definitely looking forward to more information and wondering what will happen when the market opens, not that it really matters because my shares are held long term and I have no intention of selling anytime soon. This seems like it still has much more room to run. GLTA.

    Sentiment: Strong Buy

  • Reply to

    SGEN releases latest SGN-CD19A trial results

    by redhot47fla Dec 7, 2013 10:09 AM
    desert_dweller93 desert_dweller93 Dec 7, 2013 10:16 PM Flag

    Silly question. Was this already known before today? I never got a chance to look at the ASH abstracts for SGEN so I don't know if this was already known and I am trying to figure out what impact if any today's news might have on trading on Monday. It sounds like very good, although early, results that will help show why we are not just Adcentris and we have a pipeline that could make SGEN stock price much higher in the months and years to come. GLTA hopefully today's PR was something new and we can get a nice pop on Monday.

    Sentiment: Strong Buy

  • desert_dweller93 desert_dweller93 Nov 26, 2013 9:51 PM Flag

    I just went through the form 4's for Alex for the year and he has been busy buying all year which is pretty unusual for a small company like REFR. Normally the insiders seem to treat the company shares as their own little ATM taking shares whenever they want without ever buying any on the open market. It seems as though feels very good about the company's prospects. GLTA

    Sentiment: Buy

  • Today there was a form 4 filing showing Alexander Kaganowicz, director, purchased shares today at $7.30 to add to his previous holdings which now total over 130,000 shares. Granted it was only 2,000 shares (even I bought more in the past week) but it is still a very bullish sign considering this was an open market purchase. Insiders only buy stock for one reason, because they fell it is undervalued and expect it to go up. They sell for a variety of reasons, most of which have nothing to do with the prospects of the company IMO.

    Spoke with Greg Sottile, director of market development for REFR, today. Had a very nice conversation and left the call feeling even better about my investment. GLTA

    Sentiment: Buy

  • desert_dweller93 desert_dweller93 Nov 24, 2013 6:25 PM Flag

    ND, I no longer have any OLED and have only owned it a couple of times for relatively short time periods. Same friend who likes REFR also likes OLED but I just don't have the same enthusiasm for it at these prices. Don't like all the patent issues it might have like the recent EU decision. Are there more decisions like that to come? I definitely should have held my first shares bought years ago in single digits (also sold in single digits) so I made a very bad investment move on that one. For the most part, right now I am more into biotech these days but I finally took a decent sized position (for me) in REFR and need to do more dd. I like the recent move but am concerned about its staying power at these levels unless we get some news. I normally take a very long term approach to investing and don't mind waiting it out as long as I think there is long term potential.

    I like the risk/reward with REFR much better than OLED as long as it can turn the corner and start to generate meaningful revenue. I haven't been able to find anything about the relative cost compared to non SPD glass and thought someone here might be able to point me in the right direction. I guess I should just contact the company as you suggested and I will keep digging. glta

    Sentiment: Buy

  • I have followed REFR for years due to a friend's recommendation and purchased a few shares a year ago and purchased a bunch more fairly recently, avg cost/share just under $5. To me it seems as if it could be on the verge of really breaking out as far as its financial performance is concerned if a few good things happen to it. It is such a very small company with only about a dozen employees so it won't take much revenue to start to show significant earnings. While this is my first post on this board, I have watched it occasionally for a long time.

    My biggest questions revolve around how much does incorporating REFR's technology add to the cost of glass? The reason I ask is because I would think if this could get into a significant portion of construction such as houses, office buildings etc, it would create huge opportunities. I know living in the desert where the heat of the sun in the summer is very intense, I would love to have REFR's technology in every window of my house and I am wondering why it isn't commonplace?

    Does anyone know how much it adds to the cost of the cars? If we are getting between $100-150 for each car it is incorporated into, does that mean it is adding at least $1,000 to the cost of the standard sunroof? That seems very steep to me and could be the limiting factor for mass market adoption. Would there be significant economies of scale derived from mass market adoption if it was incorporated into all/most of the cars or is this technology just that costly to produce?

    Thanks and good luck to all.

    Sentiment: Buy

  • Reply to

    junius sells

    by mershaw2001 Sep 5, 2013 6:30 PM
    desert_dweller93 desert_dweller93 Sep 6, 2013 11:52 PM Flag

    I am the person to thank for next week's pop that will happen, just sayin. I sold some trading shares at the end of the day luckily at $17.48 that I bought a couple of weeks ago at $16.30. Any time I sell trading shares you can guarantee the stock will pop after. I bought some OLED at $27 sold it at $28.60, felt good but now look at it. Like I said, just saying I am to thank for the stock popping next week. That being said, It still makes up way too much of my overall assets so I won't be too disappointed when it goes up next week :^)

    Sentiment: Strong Buy

  • Reply to

    Buyout

    by xwavve Aug 16, 2013 10:17 AM
    desert_dweller93 desert_dweller93 Aug 25, 2013 9:08 PM Flag

    koolbrez, I hope they couldn't be had for an 80% discount to the purchase price of onyx since that would mean a buyout price of only $2.5 billion, less than half of SGEN's current market cap. I think you are either talking about a different company or you have an error in your math :^)

    Sentiment: Strong Buy

  • Reply to

    As Adcetris

    by atpl1959 Aug 2, 2013 8:51 AM
    desert_dweller93 desert_dweller93 Aug 2, 2013 11:08 PM Flag

    atpi, I figure I am to thank for the run since I also sold a few shares to purchase TKMR and I really didn't want to but I really wanted to establish a position in TKMR. Usually when I sell the stocks go up and when I buy, they go down, at least temporarily. Sold at $39.65 but since I got lucky with the timing (so far at least) with TKMR I don't think I am down any$$ yet.

    I do believe SGEN will be worth several times more than the current market cap at some point in the future but considering how much I am up at this point I can't help myself but question if I should sell more. Each time the same answer comes back and it is a resounding NO. Unless the biotech party ends sooner than I expect, I really think this run in SGEN still has room to go. It sure has been fun being in SGEN for the past couple of years. I just wish I would have followed my gut and bought more when it had that Dr mention the halting of the trial that sent it temporarily into the $20's again. I wonder if that will be the last time we see them? GLTA.

    Sentiment: Strong Buy

  • Reply to

    Q2 = CHF65M

    by slumdawg2011 Jul 25, 2013 1:28 AM
    desert_dweller93 desert_dweller93 Jul 25, 2013 4:09 PM Flag

    Hamster, the other thing to remember that I failed to remember last night when posting (I guess I was tired) is that comparing the timing to Curis and SGEN is not comparing apples to apples since both of them were approved based on accelerated filing after phase 2 trials, not based on phase 3 results. So it could get approved in a quicker time frame than those. Also as you pointed out, they filed last year in the EU which I was not aware of until after making my earlier posts. All in all, we could get approval in the EU much earlier than I originally thought.

    For those who also post over on Investors Village (I don't have an account but follow it) there is a thread discussing revenue for the quarter at $88 million which is incorrect. Revenue is that high year to date, 2 quarters, not for the quarter. I believe this is very good and apparently so does the street, but I was hoping someone could post over there to correct it. GLTA and it was a good day for Curis shareholders as well due to the start of the phase 1/2 for their Roche acquired compound.

    Sentiment: Strong Buy

  • Reply to

    Q2 = CHF65M

    by slumdawg2011 Jul 25, 2013 1:28 AM
    desert_dweller93 desert_dweller93 Jul 25, 2013 1:46 AM Flag

    slumdawg, did I miss the sales numbers for Erivedge? I didn't see it in the report but I must have missed it. What was the total?

    Sentiment: Strong Buy

  • Reply to

    Q2 = CHF65M

    by slumdawg2011 Jul 25, 2013 1:28 AM
    desert_dweller93 desert_dweller93 Jul 25, 2013 1:45 AM Flag

    slumdawg, from what I have read and think II remember, the average time for CHMP recommendation is something like 13 months. I think everyone who is hoping for EU sales this year will be disappointed. For reference, Erivedge was approved by the FDA in Jan '12 and received CHMP recommendation about 2 months ago and we are still waiting on formal EU approval. A similar timeline happened with Adcentris for SGEN. Kadcyla should be on some type of accelerated path based on its need but I don't know if the EU has such a thing, do they?

    Sentiment: Strong Buy

  • Reply to

    Q2 Earnings Estimate

    by chinesehamsters Jul 12, 2013 1:33 PM
    desert_dweller93 desert_dweller93 Jul 25, 2013 1:26 AM Flag

    Looks like Kadcyla sales for the 1/2 year came in at 83 million swiss francs which I think works out to 64 million swiss francs for the qtr since I believe the first qtr was 19 million which translates into about $60-61 million USD for the qtr Looks like the IMS data was close. Let's see what the market thinks about it in the morning. To me it seems pretty good considering it has only been on the market for just a few months but I know others were expecting much higher sales. From the report:

    "The uptake of Perjeta and Kadcyla has been very encouraging so far."

    Also

    "Sales in the Pharmaceuticals Division rose 6% with Avastin, Herceptin, Actemra/RoActemra, Perjeta, MabThera/Rituxan and Kadcyla growing strongly."

    Sentiment: Strong Buy

  • Reply to

    SGEN quietly moving up

    by desert_dweller93 Jul 17, 2013 1:16 PM
    desert_dweller93 desert_dweller93 Jul 23, 2013 1:16 PM Flag

    SSSHHHHH, the stock appears to be coming back. Is it too much to ask for a new closing high today? GLTA.

    Sentiment: Strong Buy

  • Reply to

    SGEN quietly moving up

    by desert_dweller93 Jul 17, 2013 1:16 PM
    desert_dweller93 desert_dweller93 Jul 23, 2013 11:39 AM Flag

    scr, I guess I should have kept my observation to myself :^) Will we break $40 this week and what will earnings reveal next week? Have sales moved up a bit from the projections or are they staying mostly stagnant qtr to qtr? Looking forward to the earnings release on 7/31 and hoping we get some good news to keep the momentum going in the right direction. GLTA.

    Sentiment: Strong Buy

  • Reply to

    Q2 Earnings Estimate

    by chinesehamsters Jul 12, 2013 1:33 PM
    desert_dweller93 desert_dweller93 Jul 18, 2013 3:35 PM Flag

    Luckily for me most of my shares are in traditional and Roth IRA's so taxes are not a problem currently or ever for the Roth shares. I am a huge fan of Roth conversions for potentially explosive stocks. Congress gives you an opportunity to do a conversion of IMGN (or any other stock) to a Roth from a traditional IRA and you have until April of the following year to pay the tax on the value of the conversion. Best of all you can undo the conversion all the way until Oct of the following year and pretend it never happened if the stock doesn't explode by then. You can then wait 30 days and redo it if you undid it.

    For example, last Feb when SGEN was at $17, I converted shares of SGEN from a traditional IRA to a Roth. In April of this year, I paid the taxes on the value of the conversion and filed an extension. I now have until October 15th of this year to undo it if catastrophe happens and the stock plummets and I can get a refund of the taxes I paid in April. If it stays where its at or goes higher, I pay the tax once and will never have to pay tax on gains in that account, assuming Congress doesn't change the rules in the future. To use a golf analogy, it is Congress allowing you to take a Mulligan on the conversion. Speak to a tax adviser before listening to a message board post but anyone who invests in Biotechs should be doing this annually for each of their holdings in traditional IRA's IMO. I did it with Curis last year then undid it at the end of the year, waited 30 days and redid it in Jan '13. I now have until Oct 14 to make a final decision on that conversion. Keep the account separate from other Roth's until after your decision is final in order to protect the recharacterization. GLTA.

    Sentiment: Strong Buy

  • Reply to

    Q2 Earnings Estimate

    by chinesehamsters Jul 12, 2013 1:33 PM
    desert_dweller93 desert_dweller93 Jul 18, 2013 2:22 PM Flag

    Hamster, you are correct in that they are estimates and hopefully they are significantly low but I wouldn't count on it. Considering they only have the US to estimate sales for, I would think the estimates are pretty accurate and I am basing my investment decisions on those figures and past history. While I plan to just hold my shares through the earnings release and let the chips fall where they may, if we have a big run in the next few days, I may just have to sell a few with the intention of buying back after the announcement. Like I said, my short term trading is terrible and if I hold, you can almost guarantee a drop after earnings and if I sell it will be a strong buy indicator :^) GLTA

    Sentiment: Strong Buy

  • Reply to

    SGEN quietly moving up

    by desert_dweller93 Jul 17, 2013 1:16 PM
    desert_dweller93 desert_dweller93 Jul 18, 2013 2:10 PM Flag

    Boe, now let's see a run to $39.50 or higher by the end of the day. GLTA.

    Sentiment: Strong Buy

IMGN
6.26+0.09(+1.46%)2:21 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.